APRE vs BAC · $10.4M cap vs P/E 13, rev $113.10B
Aprea Therapeutics Inc (APRE) versus Bank of America Corp (BAC) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Moynihan.
APRE does not have a complete income-statement cache yet.
Latest reported BAC revenue for 2025-12-31 was $113.10B. Net income was $30.51B. Revenue was up 11.0% from 2024-12-31 to 2025-12-31. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
APRE currently screens at market cap $10.4M. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
Not investment advice. Open the APRE and BAC stock pages for the full models.
Not investment advice.